|
|
||||||||
ORIGINAL RESEARCH |


From the *School of Nursing, Indiana University, and
Department of Biostatistics, School of Medicine, Indiana University, Indianapolis, Indiana.
Address reprint requests to: Janet S. Carpenter, PhD, RN, Indiana University School of Nursing, Center for Nursing Research, 1111 Middle Drive, NU 340D, Indianapolis, IN 46202-5107; e-mail: carpentj{at}iupui.edu.
OBJECTIVE: To compare 2 subjective and 1 objective method for assessing hot flush frequency: prospective paper hot flush diaries, prospective electronic event markers, and the Biolog ambulatory sternal skin conductance monitor.
METHODS: Fifty-five breast cancer survivors provided two 24-hour periods of data, 1 week apart, at baseline before being randomized for an intervention study. Women completed a prospective paper hot flush diary and pressed an event marker to subjectively record each hot flush they experienced while wearing a sternal skin conductance monitor.
RESULTS: Sensitivity was uniformly low (< 50%) for both subjective methods at each week. The estimated probability that a woman would record a true monitor-verified hot flush subjectively by diary or event marker was between 36% and 50% of the time if she was awake and between 22% and 42% of the time if she was asleep. Underreporting of diary hot flushes consequently resulted in more than 50% missing severity and bother ratings. Specificity was high (9698%) for both the diary and event marker, for both weeks, and for both waking and sleeping times. The positive predictive value was low (3452%), and negative predictive value was high (9497%). This indicates that, rather than overreporting hot flushes when they did not exist, women tended to underreport hot flushes when they did exist.
CONCLUSION: Use of prospective paper hot flush diaries and electronic event markers may seriously underestimate hot flush frequency and result in missed intensity and bother ratings.
LEVEL OF EVIDENCE: II-2
This article has been cited by other articles:
![]() |
J. S. Carpenter and D. Flockhart Flash Points J. Clin. Oncol., December 10, 2007; 25(35): 5546 - 5547. [Full Text] [PDF] |
||||
![]() |
J. S. Carpenter, A. M. Storniolo, S. Johns, P. O. Monahan, F. Azzouz, J. L. Elam, C. S. Johnson, and R. C. Shelton Randomized, Double-Blind, Placebo-Controlled Crossover Trials of Venlafaxine for Hot Flashes After Breast Cancer Oncologist, January 1, 2007; 12(1): 124 - 135. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |